NOD2 regulation of micrornas [PDF]
Introduction Crohn's Disease (CD) is thought to arise both from defects in the gut mucosal barrier and from a dysregulated Th1/ Th17 immune response to commensal gut flora. CARD15 polymorphisms confer susceptibility to terminal ileal CD.
Brain, O +6 more
openaire +2 more sources
Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome
IntroductionBlau syndrome is a rare autosomal dominant autoinflammatory granulomatous disease caused by a mutation in the NOD2 gene. It is characterized by a clinical trial of granulomatous dermatitis, arthritis, and uveitis.
Yoko Ueki +5 more
doaj +1 more source
Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients [PDF]
Background: Epidemiological observations suggest that cancer arises from chronically inflamed tissues. Inflammatory bowel disease (IBD) is a typical example as patients with longstanding IBD are at an increased risk for developing colorectal cancer (CRC)
Zinober Kerstin +35 more
core +1 more source
Background Key hepatic molecules linking gut dysbiosis and hepatocarcinogenesis remain largely unknown. Gut-derived gut microbiota contains pathogen-associated molecular patterns (PAMPs) that may circulate into the liver and, consequently, be recognized ...
Yi Zhou +12 more
doaj +1 more source
Grimes, Catherine LeimkuhlerMicrobes are detected by specific host pattern recognition receptors (PRR) through the pathogen-associated molecular patterns (PAMPs).
Mohanan, Vishnu
core +1 more source
The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variants [PDF]
Background: The aims were to analyze two novel NOD2 variants (rs2066843 and rs2076756) in a large cohort of patients with inflammatory bowel disease and to elucidate phenotypic consequences.
Darina Czamara +65 more
core +1 more source
Structure-Activity Relationship in NOD2 Agonistic Muramyl Dipeptides
Nucleotide-binding oligomerization domain 2 (NOD2) is a receptor of the innate immune system that is capable of perceiving bacterial and viral infections.
Aarzoo, Kamboj +3 more
core +1 more source
Insights into the molecular basis of the NOD2 signalling pathway [PDF]
The cytosolic pattern recognition receptor NOD2 is activated by the peptidoglycan fragment muramyl dipeptide to generate a proinflammatory immune response.
Joseph P. Boyle +2 more
doaj +1 more source
Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening
Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is an innate immune pattern recognition receptor responsible for the recognition of bacterial peptidoglycan fragments.
Samo Guzelj +2 more
doaj +1 more source
Alterations of the CARD15/NOD2 gene and the impact on management and treatment of Crohn's disease patients [PDF]
The recent identification of the CARD15/NOD2 gene as a susceptibility locus for Crohn's disease represents an important step towards the delineation of the immuno-pathogenesis of inflammatory bowel disease.
Folwaczny, Christian +3 more
core +1 more source

